Previous studies have demonstrated that ISL may selectively inhibit prostate cancer cell proliferation by decreasing ROS levels, thus blocking AMPK and ERK signaling [102]; furthermore, this compound can suppress the invasion and metastasis of prostate cancer cells possibly via decreased JNK/AP-1 signaling [103]. This evidence concerns the gene MAPK8 and prostate carcinoma.